Acurx Pharmaceuticals, Inc. (ACXP): Price and Financial Metrics
ACXP Price/Volume Stats
| Current price | $0.88 | 52-week high | $4.42 |
| Prev. close | $0.79 | 52-week low | $0.68 |
| Day low | $0.78 | Volume | 684,800 |
| Day high | $0.91 | Avg. volume | 738,645 |
| 50-day MA | $1.11 | Dividend yield | N/A |
| 200-day MA | $1.87 | Market Cap | 15.04M |
ACXP Stock Price Chart Interactive Chart >
Acurx Pharmaceuticals, Inc. (ACXP) Company Bio
Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.
ACXP Price Returns
| 1-mo | 6.67% |
| 3-mo | -53.24% |
| 6-mo | -61.06% |
| 1-year | -77.66% |
| 3-year | -75.82% |
| 5-year | N/A |
| YTD | 8.11% |
| 2024 | -78.75% |
| 2023 | -3.77% |
| 2022 | -7.90% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...